Article Type
Case Report
Published
This article presents a case demonstrating the use of combination immunotherapy with pembrolizumab and lenvatinib in a patient with recurrent and metastatic endometrial cancer.
Case Report
This article presents a case demonstrating the use of combination immunotherapy with pembrolizumab and lenvatinib in a patient with recurrent and metastatic endometrial cancer.
Case Report
This article describes the case of a woman with deficient mismatch repair/microsatellite instability endometrial cancer who did not respond to first-line treatment with carboplatin and paclitaxel but had a high response to subsequent immunotherapy with dostarlimab.
Case Report
A clinical case report with a favourable outcome aiming to compare the patient’s response and tolerability with efficacy and toxicity data reported in clinical studies.
Case Report
This article presents a case of advanced mismatch repair proficiency/microsatellite stable endometrial carcinoma that was successfully treated with pembrolizumab plus lenvatinib
after chemotherapy failure.
Original Research
The objective of this study performed in Brazil was to understand the real-life efficacy and safety of using dupilumab in patients with moderate or severe atopic dermatitis.